Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationCell DifferentiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisMice, Inbred C57BLKidney TransplantationRecurrenceLeukemia, Myeloid, AcuteCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsBone Marrow ExaminationImmunosuppressive AgentsRemission InductionTreatment OutcomeGraft RejectionHematologic NeoplasmsBone RemodelingLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsStem Cell TransplantationTransplantation ImmunologyGraft vs Host ReactionCells, CulturedImmunosuppressionLymphocyte DepletionAcute DiseaseLymphoma, Non-HodgkinLeukocyte TransfusionT-LymphocytesHeart TransplantationColony-Forming Units AssayChimeraSevere Combined ImmunodeficiencySurvival AnalysisHLA AntigensMyelodysplastic SyndromesRetrospective StudiesLung TransplantationCyclosporineBone DensityHematologic DiseasesActuarial AnalysisLymphocyte TransfusionStem CellsFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyMice, KnockoutMice, Inbred BALB CCarmustineOrgan TransplantationSpleenPancytopeniaBone ResorptionGraft vs Tumor EffectCytarabineFollow-Up StudiesSurvival RateGraft vs Leukemia EffectLeukocyte CountGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsCell LineageGranulocytesMelphalanDisease-Free SurvivalAntigens, CD34LymphomaEtoposideMultiple MyelomaMice, TransgenicImmunophenotypingCell TransplantationFatal Outcome